UMIN000052612
Multi-center retrospective study on efficacy and safety of new-generation microwave ablation in patients with hepatocellular carcinoma
Keio University·University Hospital Medical Information NetworkNot yet recruiting
Study focus
- Disease/Condition
- Hepatocellular carcinoma
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Keio University
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Oct 26, 2023
- End date
- N/A
ICD-10 classifications
Malignant neoplasm: HepatoblastomaMalignant neoplasm: Liver cell carcinomaMalignant neoplasm: Other specified carcinomas of liverMalignant neoplasm: Liver, unspecifiedMalignant neoplasm: Hepatic flexure
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000052612
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000052612 through Pure Global AI's free database. This phase not specified trial is sponsored by Keio University and is currently Not yet recruiting. The study focuses on Hepatocellular carcinoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.